Walgreen Blasts 'Chutzpah' Of Attys' Fee Bid In Pfizer MDL
Walgreen Co. urged a New Jersey federal court Friday to deny class counsel a cut of the fees from Walgreen's antitrust settlement with Pfizer Inc. over its epilepsy treatment Neurontin, saying...To view the full article, register now.
Already a subscriber? Click here to view full article